Advisor Group Holdings »

Carisma Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $73 25 2.92
2023-09-30 $105 25 4.20
2023-06-30 $219 25 8.76
2023-03-31 $3.2k 1.0k 3.10

More positions owned by Advisor Group Holdings

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Total Usd (IUSB)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Advisor Group Holdings

Top funds holding Carisma Therapeutics

Tpg Gp A
Vanguard Group
Bank of New York Mellon
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Dimensional Fund Advisors
Blodgett Wealth Advisors
Two Sigma Investments
Jpmorgan Chase & Co
SG Americas Securities
American International

View all funds holding Carisma Therapeutics